Did the path report any high risk features (e.g. lymphovascular invasion, etc., also listed in NCCN)?
I am same stage, MSS, no high risk features, Oncotype score 7, but left sided mass. I had three Oncs give me three opinions, and all basically let me choose. I opted for adjuvant chemo with Xeloda monotherapy. I'm in the thick of it, on day 11 of cycle 4 out of 8. Get as many opinions as you need to feel comfortable with your choice. There is not a clear path based on evidence.
The 3-4% benefit was worth it to me. I say this as I punch out these words with a stylus because I've got cotton gloves over my Udderly Smooth-lathered hands. The redness and peeling and everything else... I'm okay with if it means cure.
Stage IIA rectosigmoid CC (T3N0M0)
Dx 6/5/17 @age 41, mom to 5 & 2yo girls
Workup: c-scope, EUS, rectal MRI, CT C/A/P
AdenoCA 5.5cm, WHO Grade 2, 0/22 LN, no distant mets
CEA 1.9 (6/5/17), 0.8 (2/28/18)
No lymphovasc/perineural invasion, clear margins
MSI intact, OncotypeDx RS 7
Lap sig colectomy 6/23/17, no ileo/colostomy
Genetics counseling negative for mutations, 4 VUS
Xeloda monotherapy 8/13/17-1/22/18
PET/CT 3/21/18 NED
CT C/A/P 9/17/18 NED